US$ 26.65
glp-1 alternatives for weight loss Natural GLP-1 Supplements: Experts Weigh in
Description
Eli Lilly, which also makes the weight loss drugs Mounjaro and Zepbound, said it plans to complete seven additional phase 3 clinical trials of retatrutide in 2026, compiling data that will be submitted to the U.S

2022 Dec 1;4:100047

Relevant financial disclosures: None

doi: 10.1016/j.eclinm.2023.101865, 90 LeonN.LaCoursiereR.YaroshD.PatelR

Additionally, production and supply constraints, including high manufacturing costs and limited scalability, pose significant barriers
